Evidence map›Paper›PMID 35452280›Full record

ArticleScience advances2022

Single-EV analysis (sEVA) of mutated proteins allows detection of stage 1 pancreatic cancer.

Scott Ferguson, Katherine S Yang, Piotr Zelga, Andrew S Liss, Jonathan C T Carlson, Carlos Fernandez Del Castillo, Ralph Weissleder

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 96 citations in OpenAlex.

  1. MVB Maturation Responsive to KRASJournal of extracellular vesicles · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Do drugs with biliary toxicity cause cholangiocarcinoma?bioRxiv : the preprint server for biology · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Scott FergusonCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA 02114, USA.ORCID 0000-0003-0244-8856
Katherine S YangCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA 02114, USA.ORCID 0000-0003-0182-950X
Piotr ZelgaDepartment of Surgery, Massachusetts General Hospital, 32 Fruit St, Boston, MA 02114, USA.ORCID 0000-0003-1311-7980
Andrew S LissDepartment of Surgery, Massachusetts General Hospital, 32 Fruit St, Boston, MA 02114, USA.ORCID 0000-0002-4040-9172
Jonathan C T CarlsonCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA 02114, USA.ORCID 0000-0003-4139-9057
Carlos Fernandez Del CastilloCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA 02114, USA.
Ralph WeisslederCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA 02114, USA.ORCID 0000-0003-0828-4143
Massachusetts General Hospital · USHarvard University · US

Funding

The role of microvesicles in giloma virotherapyP01CA069246 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI CHIOCCA, E. ANTONIO · 1996 to 2021
$30.9M
Training Grant in Molecular Imaging Research (MGH/HMS)T32CA079443 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2000 to 2025
$10.1M
Multiplexed analysis of exosomes in cancer nano therapyR01CA204019 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2016 to 2020
$1.9M
Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN)R01CA237332 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2020 to 2024
$1.9M
Single Circulating Vesicle Analysis for Early Cancer DetectionR21CA236561 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2019 to 2021
$585k
NCI NIH HHS P01 CA069246NCI NIH HHS R01 CA204019NCI NIH HHS R01 CA237332NCI NIH HHS R21 CA236561NCI NIH HHS T32 CA079443
6 · The paper itself

Abstract

Tumor cell-derived extracellular vesicles (EVs) are being explored as circulating biomarkers, but it is unclear whether bulk measurements will allow early cancer detection. We hypothesized that a single-EV analysis (sEVA) technique could potentially improve diagnostic accuracy. Using pancreatic cancer (PDAC), we analyzed the composition of putative cancer markers in 11 model lines. In parental PDAC cells positive for KRAS

Indexed as

Carcinoma, Pancreatic DuctalExtracellular VesiclesPancreatic NeoplasmsAtaxia Telangiectasia Mutated ProteinsHumansProto-Oncogene Proteins p21(ras)Tumor Suppressor Protein p53Ataxia Telangiectasia Mutated ProteinsProto-Oncogene Proteins p21(ras)Tumor Suppressor Protein p53

Identifiers

PMID35452280
PMCPMC9032977
OpenAlexW4225831245

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.